New immunotherapy agent offers hope for kids with cancer
January 7, 2016
The Health Science Center is the first study site in the United States to offer a clinical trial evaluating a promising new immunotherapy agent in children and young adults who do not respond well to traditional therapy or whose cancer comes back.